Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
about
A model for lupus brain diseasePrimary biliary cirrhosis and the nuclear pore complex.New-onset systemic lupus erythematosus during pregnancy.Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosisAcute hemorrhagic myositis in inflammatory myopathy and review of the literature.Novel aspects of Sjögren's syndrome in 2012.Application of fluorescent monocytes for probing immune complexes on antigen microarrays.Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesisAnti-ro52 antibodies and interstitial lung disease in connective tissue diseases excluding scleroderma2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseasesAutoantibody profiling to follow evolution of lupus syndromesCharacterization of anti-factor VIII antibody in a patient with acquired hemophilia A.PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.Primary biliary cirrhosis-specific antimitochondrial antibodies in neonatal haemochromatosis.Isolated Ro52 Antibodies as Immunological Marker of a Mild Phenotype of Undifferentiated Connective Tissue Diseases.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Routine use of Zenit RA, a novel chemiluminescent immunoanalyzer in autoimmune disease diagnosis.Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.Evaluation of a multiplex ELISA for autoantibody profiling in patients with autoimmune connective tissue diseasesER Stress Proteins in Autoimmune and Inflammatory DiseasesEvaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases.2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.Bench to bedside review of myositis autoantibodies.
P2860
Q26824461-5F5C851F-CEAC-4437-8DA5-D371C4C9E09BQ30415170-DAB3099C-32F1-4B90-B04F-6F625E909671Q33405553-6B26E220-2B1A-4452-92EA-E85E157233DCQ34186473-3528E24E-B240-41A3-B9A9-831C9131B533Q34422666-C12F55DA-C819-48BF-A890-B32B80CCC743Q34650103-050A5AF9-19BE-45F6-B022-9F60F81EAE9EQ34988379-B87622C7-CC90-4B92-99B9-EE3CE3C5C338Q35868721-F538A2B0-8A28-4E9F-8EB8-3972BD81FA73Q35893548-E40D1D12-061C-4F7D-B733-89629E35CA76Q36175647-93FFF721-2F79-478C-9566-5F53BC8C86A7Q36439998-0EE0549D-D2D6-4232-A22F-2B919F5FB7F4Q36633359-5E2DF04C-9BF9-45EF-9D4F-F4798B336EAAQ36761792-55CE94C1-EDAC-4225-93D9-B409FDD70639Q36788809-F42DE784-EB5E-44EF-8B66-A248A83E41D0Q37220305-8448193B-7616-44BC-B887-3378897F7457Q37624918-16E7FB9E-4FB9-4999-9803-B303730F3DCFQ38646384-608D895E-D7CF-441F-8E3A-9B28B7C9BDB5Q39364674-AA71AC91-77BD-4219-8E8F-FCA5078D012DQ40291320-30A28C2A-10DF-41E5-9840-D78F5BE609C5Q41915414-44BC1A41-EAB8-4B7F-8541-AFBAA4FA1550Q42144559-408263B3-7609-450A-97F3-36E6278BD29CQ46669235-CEE22C6E-C4AF-479C-8A44-015B51883A86Q51358713-4C67CB95-6C96-4C08-BC2B-B394884E0F1BQ55425108-A5796E6B-F2F5-454E-A374-D262C50BC7EF
P2860
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
@ast
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
@en
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
@nl
type
label
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
@ast
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
@en
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
@nl
prefLabel
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
@ast
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
@en
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
@nl
P2093
P1433
P1476
Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
@en
P2093
Aldo Cereda
Caterina Defendenti
Fabiola Atzeni
Giacinto Guercilena
Maria Francesca Spina
Silvia Grosso
Simona Bollani
Simone Saibeni
P304
P356
10.1016/J.AUTREV.2010.09.005
P577
2010-09-18T00:00:00Z